Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2008
10/16/2008WO2007005627A8 Tuberculosis antigen detection assays and vaccines
10/16/2008WO2006138324A3 Treponema pallidum antigens for vaccine development and diagnostic tests
10/16/2008WO2006078717A3 Lipocalin 2 for the treatment, prevention, and management of cancer metastasis, angiogenesis, and fibrosis
10/16/2008WO2006052746A8 Method of identifying compounds for bacterial growth modulation
10/16/2008WO2006036613A3 Mracs as modifiers of the rac pathway and methods of use
10/16/2008WO2006015038A3 System and method for collecting, storing, processing, transmitting and presenting very low amplitude signals
10/16/2008US20080256650 Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
10/16/2008US20080256649 Insect hydrolase for use as tool in identifying modulators which prevent mosquito propagation; genetic detection of resistance to organophosphorus and/or carbamates pesticides
10/16/2008US20080255767 Method and Device For Detection of Splice Form and Alternative Splice Forms in Dna or Rna Sequences
10/16/2008US20080255766 Methods and kits for the diagnosis of sickle cell
10/16/2008US20080255765 Monitoring cyclosporine in saliva
10/16/2008US20080255764 Methods for the Diagnosis of Colorectal Cancer and Ovarian Cancer by the Measurement of Vitamin E-Related Metabolites
10/16/2008US20080255763 System and a method for observing and predicting a physiological state of an animal
10/16/2008US20080255457 Method For Evaluating Relative Oxygen Saturation in Body Tissues
10/16/2008US20080255253 Extraneous fetal urogenital sinus or tissue from under the skin
10/16/2008US20080255243 Stat3 as a theranostic indicator
10/16/2008US20080255039 Peptide which is part of epitope in human IL-15 responsible for high-affinity binding of IL-15 to IL-15Ralpha chain, characterized in that it has sequence of region of human mature wild-type IL-15 from L44 to L52, or sequence of region of human mature wild-type IL-15 from E64 to I68 or from E64 to L69
10/16/2008US20080255028 Collagen Receptor I-Domain Binding Modulators
10/16/2008US20080255007 Substrate Material For Handling and Analyzing Samples
10/16/2008US20080255006 Using layered, high moment, superparamagnetic or antiferromagnetic nanoparticles for high-sensitivity detection of nucleic acid molecules
10/16/2008US20080255005 A two-dimensional matrix for dispersing the probe beads in a thixotropic agent, a scanner, and a spot-picker that isolates the target biomolecule; high throughput assays
10/16/2008US20080255001 Forming libraries; extracting plant extract; removal of chemical interference material; chromatographically separation into fractions; adjust concentration
10/16/2008US20080254999 Linear nucleic acid and sequence therefor
10/16/2008US20080254998 Polymer Particle
10/16/2008US20080254997 Kit, Device and Method For Analyzing Biological Substance
10/16/2008US20080254552 Methods and devices for analyte detection
10/16/2008US20080254551 Using support immobilized immunmoglobulin fusions as separation and classification tools in screening fluids for preferential analytes
10/16/2008US20080254549 Apparatus which utilizes linear array detectors to screen for labeleb nucleotide sequences; genomics and gene expression analysis
10/16/2008US20080254548 Colloid comprising self-assembled monolayer (SAM), electron transfer moiety and nucleotide sequence for use in cyclic replication and/or identification of preferential DNA sequences; genomics and gene expression analysis
10/16/2008US20080254547 Supracolonic aerodigestive neoplasm detection
10/16/2008US20080254544 Error detection and rejection for a diagnostic testing system
10/16/2008US20080254542 Reference Solution
10/16/2008US20080254520 By controlling level of carbohydrates (starch, molasses) during Penicillium biodegradation; crystalline E-8-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-isobenzofuran-5-yl)-2,6-dimethyl-oct-6-enoic acid
10/16/2008US20080254510 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
10/16/2008US20080254506 Claudin polypeptides
10/16/2008US20080254504 Method and Apparatus For Handling Tissue Samples
10/16/2008US20080254500 Microorganism-collecting chip, microorganism-collecting kit, method of quantifying microorganisms, specimen for confirming normal state of microorganism-quantifying apparatus and microorganism-quantifying apparatus
10/16/2008US20080254495 Method of Diagnosing Apoplectic Stroke/Asymptomatic Brain Infarction Using Polyamine and Acrolein Contents, Polyamine Oxidase Activity or Protein Content Thereof as Indication
10/16/2008US20080254491 Using cyclooxygenase as tool in identifying modulators of blood coagulation
10/16/2008US20080254490 Using matrix metalloprotease-9 concentration as evaluative tool in predicting early labor
10/16/2008US20080254489 Using tumor marker profiles as predicive tool in diagnosis and classification of cell proliferative disorders
10/16/2008US20080254488 Cancer Test
10/16/2008US20080254487 Immunoglobulin which intereferes with interaction of heparan sulfate proteoglycans and cell growth factors; antitumor agents; cell adhesion modulator
10/16/2008US20080254486 Using acoustic sensor comprising cellular prion protein as evaluative tool in diagnosing brain disorders associated with viral infection; variation in resonance characteristic indicator prion insult
10/16/2008US20080254485 Methods And Compositions For Monitoring And Risk Prediction In Cardiorenal Syndrome
10/16/2008US20080254484 Using site directed mutagenesis to generate acyl lipid hydrolase with decreased allergenicity; insecticides; immunotherapy; nutritional supplements
10/16/2008US20080254483 Using matrix metalloprotease-7 (MMP-7) concentration as evaluative tool in diagnosis/prognosing kidney cancer
10/16/2008US20080254482 Autoimmune disease biomarkers
10/16/2008US20080254481 Using serine/threonine kinase (PIM-1) concentration as evaluative tool in diagnosis of cell proliferative disorders
10/16/2008US20080254480 With 5-bromo2'-deoxyuridine then treating with natural killer cells, cytotoxic T lymphocytes, and/or dendritic cells; improved detection of cell necrosis and apoptosis; drug screening; immunotherapy; cancer
10/16/2008US20080254479 Using thrombospondin 2, matrix metalloprotease and/or aggrecan concentrations as evaluative tools in prognosing/diagnosing preterm delivery
10/16/2008US20080254470 Using CpG methylation patterning of paired-like homeodomain transcription factor 2 (PITX2 ) as evaluative tool in diagnosing tumor disorders
10/16/2008US20080254469 Method for Regenerating Hydrophilic and Osteophilic Surface of an Implant
10/16/2008US20080254466 Heregulin-like Factor
10/16/2008US20080254461 METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES
10/16/2008US20080254460 Using immunoaffinity chromatography to isolate cells, form maternal blood which express CD34 antigen; sexing developing fetus
10/16/2008US20080254457 Methods for Evaluating Drug-Resistance Gene Expression in the Cancer Patient
10/16/2008US20080254455 Using methylation status of glutathione S-transferase gene as evaluative tool in diagnosing prostatic cell proliferative disorders
10/16/2008US20080254452 Using plakophilin 3 (PKP3) expression as evaluative indicator of cell proliferative disorders
10/16/2008US20080254451 Using presence single nucleotide polymorphism in ciliary neurotrophic factor receptor gene as evaluative indicator in diagnosis of psychological disorders
10/16/2008US20080254448 Analysis Chip With Reference Range, Kits and Methods of Analysis
10/16/2008US20080254446 Probe complex for use in detection of severe acute respiratory syndrome corna virus and/or salmonella
10/16/2008US20080254445 Prognosis in Cancer Patients Vaccinated with a Cancer Antigen Peptide-Associated Agent
10/16/2008US20080254444 Using strips comprising preferentially immobilized ligands as diagnostic components of point of care apparatus; pregnancy, tuberculosis, prion and/or drug screening
10/16/2008US20080254442 Crystal structures of human peptide deformylase
10/16/2008US20080254440 Anti-Sars Virus Antibody, Hybridoma Producing the Antibody and Immunoassay Reagent Using the Antibody
10/16/2008US20080254173 Timer system capable of tracking several times simoultaneously
10/16/2008US20080254172 Printing on Comestible Products
10/16/2008US20080254152 Inhibiting glucocorticoid-induced chronic stress in a dermal cell or a cell involved in skin inflammatory responses
10/16/2008US20080254070 Bacterial secreted protein for use in generating vaccine for prevention of streptococcal infection; immunotherapy
10/16/2008US20080254057 Minimizing carrier-induced epitopic suppression in combination vaccines by minimizing the amount of unconjugated carrier protein; vaccines based on conjugated capsular saccharides from multiple serogroups
10/16/2008US20080254048 He4 monoclonal antibodies and methods for their use
10/16/2008US20080254044 Immunoglobulin fusion comprising cohesin-dockerin for use in targeting, treating and preventing cell proliferative disorders
10/16/2008US20080254035 Expression vector comprising lipocalin gene sequences for use in prevention and treatment of cell proliferative, inflammatory, autoimmune and cardiovascular disorders
10/16/2008US20080254034 Microbial membrane protein for use in diagnosis, prevention and treatment of gramnegative bacterial infection
10/16/2008US20080254031 Nucleotide sequences coding tumor antigens for use as diagnostic tool in detection and staging of cell proliferative disorders
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/16/2008US20080254026 Tumor necrosis factor specific immunoglobulin for use in classification, treatment and prevention of autoimmune, liver, arthritic, skin and cell proliferative disorders
10/16/2008US20080254024 Anti-ephb2 antibodies and methods using same
10/16/2008US20080254023 Using erythropoietin-producing hepatocelluar kinase receptor specific interfering RNA for treatment and prevention of brain, nervous system and spinal cord disorders
10/16/2008US20080254021 Tie1-binding ligands
10/16/2008US20080253998 Treatment of cancer using tlr3 agonists
10/16/2008US20080253991 Using glutamic acid decarboxylase (GAD) autoantigen, cd3 specific antibodies and lymphocyte specific antibodies to treat and prevent new onset type I diabetes in mammals
10/16/2008US20080253966 Diagnostic, Prognostic, and Therapeutic Factor Smac/Diablo in Human Cancer
10/16/2008US20080253929 Micro- or nano-fluidic chip fabricated with norland optical adhesive and bioanalysis platform produced by using the same
10/16/2008US20080253927 Rotational robots, defining a work perimeter; at least one device associated with each of the work perimeters, transfer stations, storage compartments
10/16/2008US20080253426 Method of Assaying a Hydrocarbon-Containing Feedstock
10/16/2008US20080252877 Inspection of Eggs in the Presence of Blood
10/16/2008US20080251585 Object scanning system with a sensing device for generating indicating data
10/16/2008US20080251393 Comprising system of electrodes operating inside reaction chamber intended to contain system of reagents in solution, system of electrodes comprising at least one working nanoelectrode series, one counter electrode and one reference electrode; for detection of biological molecules
10/16/2008US20080251378 Biosensor
10/16/2008US20080251377 Biosensor
10/16/2008DE202008010411U1 Anordnung zum Transport und/oder zur Aufbewahrung einer menschlichen oder tierischen Gewebeprobe Arrangement for transportation and / or storage of a human or animal tissue sample
10/16/2008DE202008007941U1 Vorrichtung zum Nachweis von Inhaltsstoffen in einer Flüssigkeit, insbesondere in Urin, sowie Abdeckkappe zum Abdecken der Vorrichtung An apparatus for detecting constituents in a liquid, particularly in urine, as well as covering cap for covering the device
10/16/2008DE202006020469U1 Vorrichtung zum Nachweis biochemischer Zielmoleküle Apparatus for detecting biochemical targets
10/16/2008DE112006003476T5 Verfahren und Systeme zum Nachweisen und Quantifizieren indirekter Thrombininhibitoren Methods and systems for detecting and quantifying indirect thrombin inhibitors
10/16/2008DE102007031799B3 Kanülenvorrichtung zur Entnahme von Rückenmarksflüssigkeiten (Liquor) Cannula device for the removal of spinal fluids (CSF)
10/16/2008DE102007017318A1 Verfahren zum hydrodynamischen Fokussieren eines Fluidstroms und Anordnung A method of hydrodynamic focusing of fluid flow and arrangement
10/16/2008DE102007017268A1 Arrangement for detection of target molecule, has detection area with substrate and capture molecule is arranged on substrate, which is linked to target molecule
10/16/2008DE102007017051A1 Fluorescent probe comprises two complementary hybridization sequences that are separated by a peptide with a recognition sequence for a target molecule, which also separates a donor chromophore from an acceptor chromophore